Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Trading Update

25 May 2017 07:00

RNS Number : 1609G
Huntsworth PLC
25 May 2017
 

 

Huntsworth

Trading update

 

Huntsworth plc, the healthcare communications and public relations group, is today issuing the following trading update for the four months to 30 April 2017.

 

· Group's full year results to be ahead of current consensus

· Strong trading at Huntsworth Health and Red

· Grayling trading in line with management expectations helped by UK agency returning to profit

 

Trading

 

The Group traded well through the first four months of the year, led again by strong growth at Huntsworth Health. On a like for like basis Huntsworth Health's revenues increased by over 10%, with good margin performance despite ongoing investment in talent and further diversification in two of the agencies. All of Huntsworth Health's main agencies grew in the period, led by the two largest - Evoke and Apothecom - which together account for circa 80% of divisional revenue.

 

Grayling's UK business returned to profitability in the period which means that, together with its European businesses, a large part of Grayling (representing circa 70% of annual divisional revenues) is now profitable. The US and META regions, however, remain challenging. Although we expect a decline in Grayling's like for like revenues this year, the division is trading in line with management's expectations.

 

Red has performed strongly in the period with revenues up by over 10%, with a number of new client wins. Some client churn is expected in the second half of the year which will dampen the overall annual growth rate.

 

Citigate Dewe Rogerson has experienced a mixed trading period with revenues down 2% on a like for like basis. Operations in the Netherlands, Singapore and Hong Kong have performed well, but slower transactional markets in the UK and mainland China have impacted overall revenue growth and profitability and will likely weigh on the business further during the year.

 

 

Financial Position

 

The Group remains in a strong financial position, operating well within its ÂŁ70m facility. Net debt at 19 May 2017 was c. ÂŁ31m, in line with management expectations.

 

 

Outlook

 

As a result of the stronger growth at Health and Red along with improved prospects at Grayling, we now expect the Group's full year results to be ahead of current consensus*.

 

The Group remains focused on driving operating profit by concentrating resources on its faster growing agencies and actively managing those underperforming ones. The Board is confident of continued progress through the remainder of 2017.

 

 

*Midpoint of consensus range for Headline PBT is ÂŁ19.3m

 

 

 Enquiries

 

 

Citigate Dewe Rogerson

020 7638 9571

Georgia Colkin

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUGPAUPMGQC
Date   Source Headline
31st Mar 20149:41 amRNSHuntsworth plc Notice of Preliminary Results
13th Dec 20137:00 amRNSAtomic merges with Grayling
2nd Dec 20139:37 amRNSBlocklisting Interim Review
2nd Dec 20139:34 amRNSTotal Voting Rights
28th Nov 20133:55 pmRNSAdditional Listing
13th Nov 20137:00 amRNSInterim Management Statement
8th Nov 201311:29 amRNSDirector/PDMR Shareholding
5th Nov 201312:40 pmRNSAdditional Listing
1st Nov 20139:51 amRNSTotal Voting Rights
25th Oct 20134:19 pmRNSHolding(s) in Company - Replacement
25th Oct 20132:09 pmRNSHolding(s) in Company
23rd Oct 20134:40 pmRNSHolding(s) in Company
15th Oct 20134:35 pmRNSPrice Monitoring Extension
14th Oct 20139:45 amRNSHolding(s) in Company
11th Oct 201311:27 amRNSHolding(s) in Company
10th Oct 201312:45 pmRNSTotal Voting Rights
9th Oct 201312:20 pmRNSScrip Dividend Alternative
7th Oct 20138:22 amRNSCompletion of Subscription & Director Appointment
4th Oct 201311:05 amRNSResult of GM
30th Sep 20135:14 pmRNSDirector/PDMR Shareholding
18th Sep 20134:12 pmRNSPublication of Prospectus
21st Aug 20134:22 pmRNSUpdate on proposed investment
9th Aug 20133:00 pmRNSDirector/PDMR Shareholding
8th Aug 20137:00 amRNSInterim results for the six months to 30 June 2013
1st Aug 201310:57 amRNSTotal Voting Rights
29th Jul 20132:30 pmRNSNotice of results & update on proposed investment
5th Jul 201311:56 amRNSDirector/PDMR Shareholding
3rd Jul 20131:38 pmRNSAdditional Listing
1st Jul 20139:38 amRNSTotal Voting Rights
28th Jun 201311:37 amRNSHolding(s) in Company
26th Jun 20134:15 pmRNSTreasury Stock
26th Jun 201311:26 amRNSHolding(s) in Company
24th Jun 20137:00 amRNSHuntsworth to appoint first CEO for Asia-Pacific
20th Jun 20134:56 pmRNSAdditional Listing
13th Jun 201311:38 amRNSResult of AGM
5th Jun 201312:05 pmRNSScrip Dividend Alternative
3rd Jun 20131:15 pmRNSBlocklisting Interim Review
17th May 20137:00 amRNSInterim Management Statement
14th May 20139:43 amRNSNotice of AGM
2nd May 201311:03 amRNSHolding(s) in Company
1st May 20138:56 amRNSTotal Voting Rights
30th Apr 20135:31 pmRNSAnnual Financial Report
29th Apr 20131:38 pmRNSTreasury Stock
26th Apr 20135:34 pmRNSHolding(s) in Company
26th Apr 20132:26 pmRNSDirector/PDMR Shareholding
25th Apr 20138:39 amRNSReplacement: Final Results
25th Apr 20137:01 amRNSBLUEFOCUS TO INVEST £36.5m in HUNTSWORTH
25th Apr 20137:00 amRNSFinal Results
4th Apr 20137:00 amRNSNotice of Results
5th Feb 20137:00 amRNSPre-Close Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.